---
title: "Accuray Earnings Review: Q2 Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274869036.md"
description: "Accuray (NASDAQ:ARAY) reported its Q2 earnings on February 4, 2026, missing estimated earnings by 57.14% with an EPS of $-0.11 compared to the estimate of $-0.07. Revenue decreased by $13.93 million from the previous year. In the last quarter, Accuray also missed EPS estimates, leading to a 15.86% drop in share price the following day. Past performance shows fluctuations in EPS and revenue across recent quarters."
datetime: "2026-02-04T21:14:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274869036.md)
  - [en](https://longbridge.com/en/news/274869036.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274869036.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274869036.md) | [繁體中文](https://longbridge.com/zh-HK/news/274869036.md)


# Accuray Earnings Review: Q2 Summary

**Accuray** (NASDAQ:ARAY) announced its Q2 earnings on Wednesday, February 4, 2026 at 04:05 PM.

Here's a breakdown of the earnings report.

### Earnings

Accuray missed estimated earnings by -57.14%, reporting an EPS of $-0.11 versus an estimate of $-0.07.

Revenue was down $13.93 million from the same period last year.

### Overview of Past Earnings

The company missed on EPS by $0.1 in the last quarter, resulting in a 15.86% drop share price change the following day.

Here's a look at Accuray's past performance:

**Quarter**

**Q1 2026**

**Q4 2025**

**Q3 2025**

**Q2 2025**

**EPS Estimate**

\-0.06

0.02

\-0.05

\-0.04

**EPS Actual**

\-0.16

0.01

\-0.01

0.02

**Revenue Estimate**

91.35M

124.46M

101.53M

110.36M

**Revenue Actual**

93.94M

127.54M

113.24M

116.17M

To track all earnings releases for Accuray visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [Accuray Incorporated (ARAY.US)](https://longbridge.com/en/quote/ARAY.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Boston Scientific (BSX) Gets a Hold from Erste Group](https://longbridge.com/en/news/281570952.md)
- [AngioDynamics Q3 revenue beats estimates on Med Tech strength, raises outlook](https://longbridge.com/en/news/281504186.md)
- [AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS](https://longbridge.com/en/news/281548288.md)
- [ENDRA Life Sciences Q4 net loss narrows](https://longbridge.com/en/news/281239377.md)
- [Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod | TIVC Stock News](https://longbridge.com/en/news/281187925.md)